Through the TCGA database and METABRIC database, we found that FPRL2 expression was significantly elevated in breast cancer (P < 0.05) (Figure 1A), and the expression was higher in recurrent breast cancer than in non-recurrent breast cancer tissues (P < 0.05) (Figure 1B). This evidence concerns the gene FPR3 and breast cancer.